2021 annual financial data
Estrella Immunopharma 2021 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -1,685,347 USD and net income was -1,685,347 USD.
Operating cash flow was -1,442,028 USD.
Get free Estrella Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -1,685,347 USD
- Net income
- -1,685,347 USD
- Operating cash flow
- -1,442,028 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Estrella Immunopharma financial years